Logo

The Drug Compound Rescue Effort

Nov 21, 2007

At Omics! Omics!, Keith Robison reports that Pfizer has filed a patent based on a Gene Logic drug repositioning effort. Drug repositioning is finding new uses for advanced drugs that ultimately were never approved, and Gene Logic is just one of a handful of companies hoping to make money off these compounds. The question remains, will it be the big pharmas or small biotechs that can actually get these through clinical trials? "One way to think of it is doing drug discovery, but with a compound which already has safety data on it," says Robison.

Breaking News
The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.